Robert Petryka
Impact in
- Genetics top 5%
- Inflammatory Bowel Disease
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunodeficiency and Autoimmune Disorders
- T-cell and B-cell Immunology
Papers in
- Genetics 12
- Inflammatory Bowel Disease 12
- Chronic Lymphocytic Leukemia Research 5
-
- Immunodeficiency and Autoimmune Disorders 3
- Immune Cell Function and Interaction 2
- Co-authors
- Stefan Schreiber (6 shared papers)Séverine Vermeire (5 shared papers)Maria Wiśniewska‐Jarosińska (2 shared papers)Annegret Van der Aa (4 shared papers)Maria Kłopocka (4 shared papers)Xavier Roblin (4 shared papers)Pille Harrison (4 shared papers)Chantal Tasset (4 shared papers)
- Journals
- Gastroenterology (7 papers)Journal of Crohn s and Colitis (2 papers)The American Journal of Gastroenterology (1 paper)Gut (1 paper)PLoS ONE (1 paper)
- Partner nations
- PolandGermanyUnited Kingdom
In The Last Decade
Robert Petryka
13 papers receiving 588 citations
Robert Petryka's Hit Papers
Peers
Comparison fields: 5 of 55
- Genetics 382
- Immunology 239
- Hematology 95
- Rheumatology 99
- Epidemiology 223
Countries citing papers authored by Robert Petryka
This map shows the geographic impact of Robert Petryka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Petryka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Petryka more than expected).
Fields of papers citing papers by Robert Petryka
This network shows the impact of papers produced by Robert Petryka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Petryka. The network helps show where Robert Petryka may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Petryka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2016 | 344 |
| 2 | 2013 | 110 | |
| 3 | 2016 | 60 | |
| 4 | 2016 | 34 | |
| 5 | 2017 | 27 | |
| 6 | 2016 | 9 | |
| 7 | 2014 | 4 | |
| 8 | 2016 | 2 | |
| 9 | 2007 | 1 | |
| 10 | 2015 | 1 | |
| 11 | 2015 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2017 | 1 |
About Robert Petryka
Robert Petryka is a scholar working on Genetics, Genetics, Immunology, Surgery and Epidemiology, having authored 13 papers that have together received 595 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (12 papers), Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Microscopic Colitis (3 papers), Eosinophilic Esophagitis (2 papers), Immune Cell Function and Interaction (2 papers) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Genetics (382 citations), Immunology (239 citations), Hematology (95 citations), Rheumatology (99 citations) and Epidemiology (223 citations). Robert Petryka has collaborated with scholars based in Poland, Germany and United Kingdom. Frequent co-authors include Stefan Schreiber, Séverine Vermeire, Maria Wiśniewska‐Jarosińska, Annegret Van der Aa, Maria Kłopocka, Xavier Roblin, Pille Harrison, Chantal Tasset, Tanja Kuehbacher and Róbert Sike. Their work appears in journals such as Gastroenterology, Journal of Crohn s and Colitis, The American Journal of Gastroenterology, Gut and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.